IGF1 and gastrin-producing neuroendocrine tumor: To our knowledge, the only study addressing the prognostic role of IGF-1R in NETs patients was led by Furukawa et al. who investigated IGF and IGF-1R expression in 54 gastrinomas by means of RT-PCR for mRNA and IHC.